Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • iBlastoids: Reprogrammed skin cells as a Human Embryo

Understanding Allogeneic adipose-derived stem cell

New species of bacterial strains discovered at the International Space Station!

iBlastoids: Reprogrammed skin cells as a Human Embryo
  • BiotechToday
  • World

iBlastoids: Reprogrammed skin cells as a Human Embryo

bioxone March 23, 2021March 23, 2021

Devyani Goswami, Amity University Kolkata

JosĂ© M. Polo, PhD, a professor of anatomy and developmental biology at Monash University, discovered a way to generate induced blastoids or iBlastoids that imitates the natural human blastoids; made up of reprogrammed skin cells. Molecular and functional assays were performed to demonstrate that the structures were blastocyst-like structures that could model several aspects of blastocyst biology. 

These iBlastoidshas an inner cell mass-like structure, with epiblast- and primitive endoderm-like cells, a blastocoel-like cavity, and a trophectoderm-like outer layer of cells; similar to a human blastocyst. Further single-cell transcriptomics confirmed the presence of epiblast-, primitive endoderm-, and trophectoderm-like cells in the iBlastoids. iBlastoids can give rise to pluripotent and trophoblast stem cells and are competent enough of modelling, in vitro.

This study was conducted to learn the early steps in human development, and some of the causes of infertility, congenital diseases in early embryos, without the use of human blastocysts. The use of human blastocyst after 14 days is considered to be unethical, hence the study was conducted with a blastocyst of 11 days. There remain certain differences between the blastocyst and iBlastoids. iBlatoids lacks the zona pellucid since they are derived from the fibroblast. 

The use of iBlastoids remains under ethical and legislative constraints, even though it promises to understand and solve the problems related to early miscarriages.

Also read:Understanding Allogeneic adipose-derived stem cell

Source:

Modelling human blastocysts by reprogramming fibroblasts into iBlastoids https://www.nature.com/articles/s41586-021-03372-y

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged blastoids developmental biology human embryo iBlastoids reprogrammed skin cells

One thought on “iBlastoids: Reprogrammed skin cells as a Human Embryo”

  1. Pingback: New species of bacterial strains discovered at the International Space Station! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

New species of bacterial strains discovered at the International Space Station!

bioxone March 23, 2021

Ayooshi Mitra, Amity University Kolkata The International Space Station, also known as ISS, is an orbital laboratory located in low-Earth orbit (LEO) that has hosted numerous astronauts for maintenance and scientific experiments in its microgravity environment. Over the last six years, astronauts from various crews have collected samples from eight different locations on the space […]

bacterial strain

Related Post

  • BiotechToday
  • World

First interchangeable biosimilar insulin for diabetic patients

bioxone August 2, 2021August 1, 2021

Komal Bavaskar, Mumbai university Diabetes affects around 422 million people globally, with the majority residing in low- and middle-income countries, and diabetes is directly responsible for 1.6 million mortality per year. Diabetes has already been diagnosed in over 30 million people in India. What is diabetes? It is a metabolic disorder that results in elevated […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

CDK9: A Key regulator of RNA Polymerase II Transcription

bioxone June 24, 2021June 23, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi It has been discovered that Cyclin-Dependent Kinase 9 (CDK9) is an important regulator of RNA Polymerase II transcription. As a regulator CDK9 works across the transcription unit at multiple locations. These include the transcriptional pause release before elongation by the action of positive transcription elongation factor b (P-TEFb). […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Turbinmicin- A New Fighter

bioxone November 28, 2020November 28, 2020

Shrayana Ghosh, Amity University Kolkata A new antifungal compound, discovered by the scientists of the University of Wisconsin-Madison, Madison that can target the multidrug-resistant and potentially deadly strains of the fungal pathogen Candida auris without causing any toxic side effects in mice. The team discovered a new molecule detected in the microbiome of a sea squirt from […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy